Cargando…

Real‐world experience of nivolumab in the treatment of poor performance status patients with advanced non‐small cell lung cancer

BACKGROUND: Nivolumab improves disease control and survival in advanced NSCLC in patients with good performance status (PS), but there is limited data on its efficacy in patients with poor PS. AIM: Primary objective of the study was to evaluate the efficacy and safety of nivolumab and examine the in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abbas, M. Nazim, Klevansky, Myron, Koczwara, Bogda, Roy, Amitesh Chandra, Sukumaran, Shawgi, Vatandoust, Sina, Karapetis, Christos Stelios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955060/ https://www.ncbi.nlm.nih.gov/pubmed/34196124 http://dx.doi.org/10.1002/cnr2.1487

Ejemplares similares

Predicting chemotherapy‐induced menopause using baseline and post‐chemotherapy anti‐Müllerian hormone levels: Results of a pilot study
por: Martin, Hilary Laura, et al.
Publicado: (2021)

Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol
por: Vatandoust, Sina, et al.
Publicado: (2019)

Pemetrexed-Induced Interstitial Pneumonitis: A Case Study and Literature Review
por: Waters, Michael J., et al.
Publicado: (2014)

Real-World Data on Outcomes in Metastatic Castrate-Resistant Prostate Cancer Patients Treated With Abiraterone or Enzalutamide: A Regional Experience
por: Raju, Rachel, et al.
Publicado: (2021)

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
por: Reece, Mifanwy, et al.
Publicado: (2019)

Cardiotoxicity after cancer treatment: a process map of the patient treatment journey
por: Clark, Robyn A., et al.
Publicado: (2019)

Nivolumab-induced synovitis is characterized by florid T cell infiltration and rapid resolution with synovial biopsy-guided therapy
por: Murray-Brown, William, et al.
Publicado: (2020)

Health status and mental distress in people with cancer and comorbid conditions: The Australian National Health Survey analysis
por: Ng, Huah Shin, et al.
Publicado: (2023)

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
por: Asher, Nethanel, et al.
Publicado: (2020)

Is there an Exposure–Response Relationship for Nivolumab in Real-World NSCLC Patients?
por: Bellesoeur, Audrey, et al.
Publicado: (2019)

Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2023)

Rethinking cancer survivorship: the Prostate Cancer Survivorship Essentials Framework
por: Dunn, Jeff, et al.
Publicado: (2021)

Finding My Way from clinical trial to open access dissemination: comparison of uptake, adherence, and psychosocial outcomes of an online program for cancer-related distress
por: Beatty, Lisa, et al.
Publicado: (2022)

Financial toxicity and employment status in cancer survivors. A systematic literature review
por: Mols, Floortje, et al.
Publicado: (2020)

Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
por: Wu, Wen-Chi, et al.
Publicado: (2022)

Shared care involving cancer specialists and primary care providers – What do cancer survivors want?
por: Lawn, Sharon, et al.
Publicado: (2017)

Finding My Way: protocol of a randomised controlled trial evaluating an internet self-help program for cancer-related distress
por: Beatty, Lisa, et al.
Publicado: (2015)

Modality preferences for health behaviour interventions for post-treatment cancer survivors: a theoretical investigation
por: Leske, Morgan, et al.
Publicado: (2023)

Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
por: Lim, Sun Min, et al.
Publicado: (2020)

Psychosocial impact of COVID-19 on cancer patients, survivors, and carers in Australia: a real-time assessment of cancer support services
por: Edge, Rhiannon, et al.
Publicado: (2021)

Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
por: Kuo, Hsin-Yu, et al.
Publicado: (2022)

Bilateral intermediate uveitis following treatment with paclitaxel in a patient with invasive ductal carcinoma of the breast
por: Kvopka, Michael, et al.
Publicado: (2022)

Validation of a Short Food Frequency Questionnaire to Measure Dietary Intake of a Selection of Micronutrients in Oncology Patients Undergoing Systemic Therapy
por: Mukherjee, Mitali S., et al.
Publicado: (2021)

Regorafenib Versus Nivolumab After Sorafenib Failure: Real‐World Data in Patients With Hepatocellular Carcinoma
por: Choi, Won‐Mook, et al.
Publicado: (2020)

Real‐World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma
por: Samlowski, Wolfram, et al.
Publicado: (2022)

Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses
por: Matsumoto, Toshihiko, et al.
Publicado: (2020)

Incidence of Comorbidities in Women with Breast Cancer Treated with Tamoxifen or an Aromatase Inhibitor: An Australian Population-Based Cohort Study
por: Ng, Huah Shin, et al.
Publicado: (2018)

The real-world experience with nivolumab in previously treated patients with advanced non-small cell lung cancer from a cancer center in India
por: Abbas, Waseem, et al.
Publicado: (2020)

Real‐world safety of nivolumab in patients with non‐small‐cell lung cancer in Japan: Postmarketing surveillance
por: Yamamoto, Nobuyuki, et al.
Publicado: (2021)

A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic
por: Church, Matt, et al.
Publicado: (2021)

Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA
por: Laliberté, François, et al.
Publicado: (2020)

Serial monitoring of LV function following chemotherapy: assessment using advanced echocardiography and cardiovascular magnetic resonance
por: Grover, Suchi, et al.
Publicado: (2014)

Cancer survivorship care during COVID-19—perspectives and recommendations from the MASCC survivorship study group
por: Chan, Alexandre, et al.
Publicado: (2020)

Real Check RIO: A Real-World Analysis of Nivolumab in First Line Metastatic Melanoma Assessing Efficacy, Safety and Predictive Factors
por: Afrăsânie, Vlad-Adrian, et al.
Publicado: (2023)

Real World Evidence: methodological issues and opportunities from the European Health Data Space
por: Kympouropoulos, Stelios
Publicado: (2023)

Comorbidities and their management in women with breast cancer—an Australian survey of breast cancer survivors
por: Koczwara, Bogda, et al.
Publicado: (2023)

Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection
por: Sung, Pil Soo, et al.
Publicado: (2020)

Effectiveness and Safety of Nivolumab in Child–Pugh B Patients with Hepatocellular Carcinoma: A Real-World Cohort Study
por: Choi, Won-Mook, et al.
Publicado: (2020)

Nivolumab in pre-treated malignant pleural mesothelioma: real-world data from the Dutch expanded access program
por: Cantini, Luca, et al.
Publicado: (2020)

Real-World Outcomes and Prognostic Factors in Patients Receiving Nivolumab Therapy for Recurrent or Metastatic Head and Neck Carcinoma
por: Hori, Ryusuke, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2is52boonl9njsj09bao3hddgd